Battling the economic burden of drug resistance a global challenge

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.489, 2005-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Clinical Update and Global Economic Burden of Rheumatoid Arthritis

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 18, Iss. 2, 2018-02 ,pp. : 98-109

Bentham Science Publishers

Access to resources Recommend Favorite

Antitubercular drug resistance remains a global concern

Inpharma, Vol. 1, Iss. 1569, 2007-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Understanding the Global Problem of Drug Addiction is a Challenge for IDARS Scientists

Current Neuropharmacology, Vol. 9, Iss. 1, 2011-03 ,pp. : 2-7

Bentham Science Publishers

Access to resources Recommend Favorite

Antituberculosis drug resistance: new global data on an emerging global emergency

By Chapman Ann LN

Clinical Medicine, Vol. 8, Iss. 5, 2008-10 ,pp. : 478-479

Royal College Of Physicians

Access to resources Recommend Favorite

Economic burden of osteoarthritis in the US

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 596, 2010-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite